Institutional Implementation Publications

top of page

Use tab to navigate through the menu items.

Search

Clinical Recommendations Draft Guidance

IND Submissions for Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases:...

81

First Name

Credentials (MD, PhD, etc)

Affiliation(s)

Relationship * Required

Clinician (physician

Researcher / investigator

Patient

Other

Last Name

Email

Country

Area(s) of Interest * Required

General interest

Patient identification and selection

Trial implementation

Clinical outcome measures

Toxicology and safety

Data sharing

Ethics and equity

Other

What brought you to the N=1 Collaborative? What are you hoping to gain, contribute, learn, or participate in?

Thanks for submitting!

501c3 Nonprofit Organization

EIN: 88-2591503

bottom of page